BCBS North Dakota

Does BCBS North Dakota cover Zepbound?

Quick answer · Weight Loss

BCBS North Dakota covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance and ACA Marketplace.

  • Employer / Commercial Insurance: Covered with requirements. BMI of 30 or higher
  • ACA Marketplace: Covered with requirements. BMI of 30 or higher

Last verified June 2, 2026. Policy effective April 20, 2026. Source: ND_Weight_Management_PAQL_ProgSum.pdf. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What BCBS North Dakota requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

  • BMI >= 30 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

  • BMI >= 27 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

  • Hypertension
  • Type 2 diabetes
  • Dyslipidemia
  • Obstructive sleep apnea
  • Cardiovascular disease
  • Other weight-related comorbid condition

Documentation to bring

  • Documentation of BMI >= 30 kg/m2 or >= 27 kg/m2 with at least one weight-related comorbidity
  • Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
  • Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

  • To renew, the plan looks for at least 5% weight loss from the starting weight, Per referenced guidelines, if weight loss >= 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued, and at least 12 weeks on therapy before the first renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: Zepbound is available as subcutaneous injection vial and KwikPen formulations. FDA indication is for adults only. Full PA criteria details beyond FDA indication summary and referenced guidelines are not enumerated in the provided document text.

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

  • BMI >= 30 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

  • BMI >= 27 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

  • Hypertension
  • Type 2 diabetes
  • Dyslipidemia
  • Obstructive sleep apnea
  • Cardiovascular disease
  • Other weight-related comorbid condition

Documentation to bring

  • Documentation of BMI >= 30 kg/m2 or >= 27 kg/m2 with at least one weight-related comorbidity
  • Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
  • Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

  • To renew, the plan looks for at least 5% weight loss from the starting weight, Per referenced guidelines, if weight loss >= 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued, and at least 12 weeks on therapy before the first renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: Zepbound is available as subcutaneous injection vial and KwikPen formulations. FDA indication is for adults only. Full PA criteria details beyond FDA indication summary and referenced guidelines are not enumerated in the provided document text.

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

Zepbound for Osa

What BCBS North Dakota requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Diagnosed obstructive sleep apnea

Qualification pathways

You can qualify through any one of these.

Moderate to severe OSA in adults with obesity

All of:

  • Adult patient (age >= 18)
  • Diagnosis of moderate to severe obstructive sleep apnea (OSA)
  • Obesity (BMI >= 30 kg/m2)

Documentation to bring

  • Documentation of moderate to severe OSA diagnosis
  • Documentation of obesity (BMI >= 30 kg/m2)

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: FDA indication listed as moderate to severe OSA in adults with obesity. Specific AHI threshold, PAP trial requirement, and other OSA-specific PA criteria are not enumerated in the provided document text — only the FDA indication summary is presented. Document does not specify 'moderate to severe' in terms of AHI cutoff values.

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Diagnosed obstructive sleep apnea

Qualification pathways

You can qualify through any one of these.

Moderate to severe OSA in adults with obesity

All of:

  • Adult patient (age >= 18)
  • Diagnosis of moderate to severe obstructive sleep apnea (OSA)
  • Obesity (BMI >= 30 kg/m2)

Documentation to bring

  • Documentation of moderate to severe OSA diagnosis
  • Documentation of obesity (BMI >= 30 kg/m2)

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: FDA indication listed as moderate to severe OSA in adults with obesity. Specific AHI threshold, PAP trial requirement, and other OSA-specific PA criteria are not enumerated in the provided document text — only the FDA indication summary is presented. Document does not specify 'moderate to severe' in terms of AHI cutoff values.

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

Why Zepbound requests get denied by BCBS North Dakota

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. No documented diet and exercise program.
  5. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does BCBS North Dakota cover Zepbound?
BCBS North Dakota covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance and ACA Marketplace.
What BMI do you need for Zepbound under BCBS North Dakota?
For weight loss on Employer / Commercial Insurance plans, BCBS North Dakota requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition. Other plan types may differ — see each plan type below.
What does BCBS North Dakota require to renew Zepbound?
At least 5% weight loss from the starting weight, Per referenced guidelines, if weight loss >= 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued, and at least 12 weeks on therapy before the first renewal.
How current is this information?
This page reflects BCBS North Dakota's written policy as of April 20, 2026, last verified against the source document on June 2, 2026.

Other medications under BCBS North Dakota

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes BCBS North Dakota's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.